Why ‘Normal’ LDL Cholesterol May Not Be Safe for Future Moms

CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population

Cytokinetics to Announce Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy, on May 5, 2026

FDA details Class I catheter recall over safety risk

Advanced AI helps 3D imaging labs evolve with the times

New ways to predict TAVR outcomes for individual heart patients

Simple Steps to Address Spirituality With Patients

Data Trends: Heart Failure

Heart Failure Hospitalizations Rose in Younger Patients

TruLeaf Medical, a fully-owned subsidiary of Allmed Solutions successfully Completed the Second Stage of valve implantation in two Additional Patients